Akido’s ScopeAI is a first-of-its-kind system that absolutely integrates AI right into a supplier go to
LOS ANGELES–(BUSINESS WIRE)–Akido Labs, Inc. (“Akido”), the AI and care supply firm reimagining healthcare, right this moment introduced it has raised $60 million in Sequence B funding. The spherical was led by Oak HC/FT with participation from Greco, SNR, and current buyers Y Combinator, Future Communities Capital, Jeff Dean (Chief Scientist, Google DeepMind & Google Analysis), and the Complete Blood & Most cancers Middle. Funding will likely be used to increase the attain of ScopeAI, a system that will increase medical capability and improves healthcare entry.
ScopeAI is remodeling how Akido suppliers apply drugs – enabling them to look after dramatically extra sufferers with out compromising on high quality. This unlocks time for suppliers to concentrate on advanced instances, whereas rising the full variety of sufferers the system can assist. The U.S. inhabitants requires over 3 billion physician visits per 12 months, but solely 825 million are presently out there. The result’s longer waits, particularly for specialists, rushed appointments, and rising charges of preventable illness. Akido is addressing this disaster by embedding highly effective medical intelligence immediately into the medical workflow – bringing scale, effectivity, and consistency to the entrance strains of care.
“We constructed ScopeAI to deal with the one greatest problem going through healthcare programs worldwide: the doctor scarcity. With demand for care far exceeding provide, AI is the important thing to addressing the worldwide physician deficit, empowering healthcare suppliers, and guaranteeing sufferers obtain the well timed, high-quality care they deserve, no matter monetary means or geography,” mentioned Prashant Samant, Co-Founder & CEO of Akido. “At Akido, we consider distinctive healthcare is a fundamental human proper. Our work has at all times targeted on democratizing high-quality healthcare, and this funding allows us to speed up that mission.”
In a ScopeAI go to, a educated Medical Assistant (MA) meets with a affected person, guided by clever prompts from ScopeAI all through the encounter. ScopeAI makes use of medical reasoning to actively pay attention, adapt in actual time, and construct a complete understanding of the affected person’s situation. Its scribing and auditory capabilities enable for dynamic dialog whereas concurrently producing a full medical report, together with a preliminary analysis, remedy plan, and justification log for every determination it makes. With ScopeAI, suppliers achieve a deeper, extra full image of a affected person’s well being with much less time spent capturing it. An Akido supplier can oversee a crew of MAs conducting ScopeAI visits, rising entry to care whereas enabling the supplier to concentrate on higher-acuity or extra advanced instances.
Akido’s AI-based healthcare visits have delivered 5x extra face-to-face time with sufferers and have achieved a 96 NPS rating. With this new funding, Akido will speed up the event and deployment of ScopeAI all through its Akido Care medical community of 240 suppliers throughout 26 specialties. It can additionally assist assist Akido’s entrance into new markets just like the just lately introduced first-of-its-kind healthcare program in New York Metropolis that’s designed to handle particular continual illnesses for skilled rideshare and for-hire drivers.
“Akido is delivering on the promise of fixing how sufferers expertise a go to with their supplier by way of AI,” mentioned Andrew Adams, Co-Founder & Managing Associate at Oak HC/FT. “With its strong, longitudinal dataset, Akido has the refinement in its foundational mannequin to supply medical accuracy the place others have struggled. We’re excited to associate with their distinctive crew of healthcare and technical operators to scale ScopeAI, increasing entry to high-quality, AI-powered look after extra sufferers.”
Akido was based in 2015 with the aim of reimagining healthcare for traditionally weak communities by leveraging AI and machine studying. In 2022, Akido launched Akido Care, a medical community that right this moment contains almost 100 clinics, providing main and specialty care throughout 26 sub-specialties. This twin technique is what created the chance for Akido to leverage its proprietary dataset of over 10 million affected person case research and reinforcement-loop-human-feedback (RLHF) setting to launch ScopeAI. ScopeAI is likely one of the most subtle medical AI programs out there to suppliers, and it’s repeatedly refined by incorporating real-time supplier suggestions. By integrating ScopeAI into the Akido Care medical community, Akido is positioned to empower suppliers to ship extremely personalised care to a person affected person whereas additionally scaling packages at a inhabitants degree.
About Akido
Akido is pioneering a reimagined healthcare system with AI at its core; one which bridges synthetic intelligence and empathy to deliver distinctive healthcare to everybody. Its breakthrough know-how unlocks the flexibility to rework the medical expertise, empowering suppliers and sufferers by way of a completely new healthcare mannequin. Based in 2015, Akido was created out of the College of Southern California’s Digital Well being Lab with the concept that empowering authorities, healthcare, and nonprofit companies with population-based knowledge might assist usher in a brand new period of preventive public well being. Recognized for creating award-winning knowledge and know-how options, right this moment Akido leverages its market-leading know-how to energy its bicoastal Akido Care medical community, which incorporates greater than 240 suppliers and 90 clinics throughout each coasts and a affected person base of almost half 1,000,000. For extra data, please go to www.akidolabs.com.
About Oak HC/FT
Oak HC/FT is a enterprise and development fairness agency specializing in investments in fintech and healthcare. Utilizing partnership as a basis, Oak HC/FT guides firms and founders at each stage, from seed to development, to create companies that make a measurable and lasting affect. Based in 2014, Oak HC/FT has invested in over 85 portfolio firms and has over $5.3 billion in property underneath administration. Oak HC/FT is headquartered in Stamford, CT, with an workplace in San Francisco, CA. Observe Oak HC/FT on LinkedIn and X and study extra at https://www.oakhcft.com/.
Contacts
Media
Jackie Kahn, jackie@oakhcft.com
Akido’s ScopeAI is a first-of-its-kind system that absolutely integrates AI right into a supplier go to
LOS ANGELES–(BUSINESS WIRE)–Akido Labs, Inc. (“Akido”), the AI and care supply firm reimagining healthcare, right this moment introduced it has raised $60 million in Sequence B funding. The spherical was led by Oak HC/FT with participation from Greco, SNR, and current buyers Y Combinator, Future Communities Capital, Jeff Dean (Chief Scientist, Google DeepMind & Google Analysis), and the Complete Blood & Most cancers Middle. Funding will likely be used to increase the attain of ScopeAI, a system that will increase medical capability and improves healthcare entry.
ScopeAI is remodeling how Akido suppliers apply drugs – enabling them to look after dramatically extra sufferers with out compromising on high quality. This unlocks time for suppliers to concentrate on advanced instances, whereas rising the full variety of sufferers the system can assist. The U.S. inhabitants requires over 3 billion physician visits per 12 months, but solely 825 million are presently out there. The result’s longer waits, particularly for specialists, rushed appointments, and rising charges of preventable illness. Akido is addressing this disaster by embedding highly effective medical intelligence immediately into the medical workflow – bringing scale, effectivity, and consistency to the entrance strains of care.
“We constructed ScopeAI to deal with the one greatest problem going through healthcare programs worldwide: the doctor scarcity. With demand for care far exceeding provide, AI is the important thing to addressing the worldwide physician deficit, empowering healthcare suppliers, and guaranteeing sufferers obtain the well timed, high-quality care they deserve, no matter monetary means or geography,” mentioned Prashant Samant, Co-Founder & CEO of Akido. “At Akido, we consider distinctive healthcare is a fundamental human proper. Our work has at all times targeted on democratizing high-quality healthcare, and this funding allows us to speed up that mission.”
In a ScopeAI go to, a educated Medical Assistant (MA) meets with a affected person, guided by clever prompts from ScopeAI all through the encounter. ScopeAI makes use of medical reasoning to actively pay attention, adapt in actual time, and construct a complete understanding of the affected person’s situation. Its scribing and auditory capabilities enable for dynamic dialog whereas concurrently producing a full medical report, together with a preliminary analysis, remedy plan, and justification log for every determination it makes. With ScopeAI, suppliers achieve a deeper, extra full image of a affected person’s well being with much less time spent capturing it. An Akido supplier can oversee a crew of MAs conducting ScopeAI visits, rising entry to care whereas enabling the supplier to concentrate on higher-acuity or extra advanced instances.
Akido’s AI-based healthcare visits have delivered 5x extra face-to-face time with sufferers and have achieved a 96 NPS rating. With this new funding, Akido will speed up the event and deployment of ScopeAI all through its Akido Care medical community of 240 suppliers throughout 26 specialties. It can additionally assist assist Akido’s entrance into new markets just like the just lately introduced first-of-its-kind healthcare program in New York Metropolis that’s designed to handle particular continual illnesses for skilled rideshare and for-hire drivers.
“Akido is delivering on the promise of fixing how sufferers expertise a go to with their supplier by way of AI,” mentioned Andrew Adams, Co-Founder & Managing Associate at Oak HC/FT. “With its strong, longitudinal dataset, Akido has the refinement in its foundational mannequin to supply medical accuracy the place others have struggled. We’re excited to associate with their distinctive crew of healthcare and technical operators to scale ScopeAI, increasing entry to high-quality, AI-powered look after extra sufferers.”
Akido was based in 2015 with the aim of reimagining healthcare for traditionally weak communities by leveraging AI and machine studying. In 2022, Akido launched Akido Care, a medical community that right this moment contains almost 100 clinics, providing main and specialty care throughout 26 sub-specialties. This twin technique is what created the chance for Akido to leverage its proprietary dataset of over 10 million affected person case research and reinforcement-loop-human-feedback (RLHF) setting to launch ScopeAI. ScopeAI is likely one of the most subtle medical AI programs out there to suppliers, and it’s repeatedly refined by incorporating real-time supplier suggestions. By integrating ScopeAI into the Akido Care medical community, Akido is positioned to empower suppliers to ship extremely personalised care to a person affected person whereas additionally scaling packages at a inhabitants degree.
About Akido
Akido is pioneering a reimagined healthcare system with AI at its core; one which bridges synthetic intelligence and empathy to deliver distinctive healthcare to everybody. Its breakthrough know-how unlocks the flexibility to rework the medical expertise, empowering suppliers and sufferers by way of a completely new healthcare mannequin. Based in 2015, Akido was created out of the College of Southern California’s Digital Well being Lab with the concept that empowering authorities, healthcare, and nonprofit companies with population-based knowledge might assist usher in a brand new period of preventive public well being. Recognized for creating award-winning knowledge and know-how options, right this moment Akido leverages its market-leading know-how to energy its bicoastal Akido Care medical community, which incorporates greater than 240 suppliers and 90 clinics throughout each coasts and a affected person base of almost half 1,000,000. For extra data, please go to www.akidolabs.com.
About Oak HC/FT
Oak HC/FT is a enterprise and development fairness agency specializing in investments in fintech and healthcare. Utilizing partnership as a basis, Oak HC/FT guides firms and founders at each stage, from seed to development, to create companies that make a measurable and lasting affect. Based in 2014, Oak HC/FT has invested in over 85 portfolio firms and has over $5.3 billion in property underneath administration. Oak HC/FT is headquartered in Stamford, CT, with an workplace in San Francisco, CA. Observe Oak HC/FT on LinkedIn and X and study extra at https://www.oakhcft.com/.
Contacts
Media
Jackie Kahn, jackie@oakhcft.com
